Effect of standard Iron Folic Acid Supplementation on Gut Modulation and Hemoglobin improvement among Anemic Adolescents

Phase 4

• Conditions: Health Condition 1: D509- Iron deficiency anemia, unspecified

• Registration Number: CTRI/2019/02/017806
• Lead Sponsor: ICMRNational Institute of Nutrition

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Apparently healthy young girls (17-20 years) having normal hemoglobin and mild to moderate anemia who are willing to give consent will be included.

Exclusion Criteria

1. Anemic adolescent girls with presence of thalassemia, sickle cell anemia, Hemochromatosis, Chronic gastric diseases (IBD, Crohnâ??s disease, gastric ulcers, celiac disease, hemorrhagic disease) and renal disease will be excluded from the study

2. Subjects with excessive bleeding during menstrual cycles

3. Subjects who have consumed any antibiotics, antacids, probiotics, prebiotics, and medications containing alcohol or any other products capable of drastically altering the gut microbiome, within a period of at least four weeks before fecal sample collection will also be excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Gut modulation and Other Iron status MarkersTimepoint: 90 days

Secondary Outcome Measures

Name	Time	Method
Hemoglobin and Serum Iron Biostatus markersTimepoint: 0 day to 180 days <br/ ><br>0 day to 365 days